N
KRRO icon

Nuveen’s Korro Bio KRRO Stock Holding History

Nuveen’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,264
Closed -$444K – 3275
2025
Q3 		$444K Buy
+9,264
New +$206K ﹤0.01% 2937
2025
Q2 		– Sell
-12,145
Closed -$211K – 3336
2025
Q1 		$211K Sell
12,145
-16,150
-57% -$479K ﹤0.01% 3124
2024
Q4 		$1.08M Buy
28,295
+17,131
+153% +$880K ﹤0.01% 2680
2024
Q3 		$373K Hold
11,164
– – ﹤0.01% 3100
2024
Q2 		$378K Buy
+11,164
New +$617K ﹤0.01% 3085
2022
Q2 		– Sell
-2,733
Closed -$4.96M – 3380
2022
Q1 		$4.96M Buy
2,733
+47
+2% +$8.98K ﹤0.01% 2066
2021
Q4 		$4.87M Sell
2,686
-226
-8% -$68.7K ﹤0.01% 2136
2021
Q3 		$5.28M Buy
2,912
+153
+6% +$60.2K ﹤0.01% 2179
2021
Q2 		$5.01M Buy
2,759
+764
+38% +$373K ﹤0.01% 2246
2021
Q1 		$3.62M Sell
1,995
-3
-0.2% -$5.83K ﹤0.01% 2327
2020
Q4 		$3.52M Buy
1,998
+4
+0.2% +$5.28K ﹤0.01% 2245
2020
Q3 		$1.92M Sell
1,994
-438
-18% -$470K ﹤0.01% 2404
2020
Q2 		$2.83M Buy
+2,432
New +$2.2M ﹤0.01% 2188

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Nuveen's KRRO Position: Q4 2025 in Review

Nuveen sold out of Korro Bio (KRRO) in Q4 2025, closing a stake of 9,264 shares — an estimated $444K sold.

Nuveen first reported a position in KRRO in Q2 2020 and held it in 13 quarters. The position peaked at $5.28M in Q3 2021. 83 funds tracked by Wall St. Rank hold KRRO as of Q4 2025.

  • Nuveen reported no remaining Korro Bio position as of Q4 2025 after selling out during the quarter.
  • Nuveen sold 9,264 Korro Bio shares in Q4 2025, an estimated $444K.
  • Nuveen first reported a position in Korro Bio in Q2 2020 and held it in 13 quarters.
  • Nuveen's Korro Bio position peaked at $5.28M in Q3 2021.
  • 83 funds tracked by Wall St. Rank held Korro Bio as of Q4 2025.

Based on Nuveen's 13F filing for Q4 2025, filed 12 Feb 2026.